Precision Neuroscience has raised $250.0M in Series D funding, bringing the brain-computer interface developer's total backing to more than $405 million since its 2021 founding.
The New York鈥揵ased company is building a brain implant designed to let people with paralysis control computers and smartphones with their thoughts alone, with potential applications in spinal cord injury, stroke, and ALS. The round was led by Pershing Square and the Ackman Oxman Institute. Precision has already begun human trials with several top U.S. hospitals, and says it is now among the best-capitalized companies in the emerging BCI field.

















